Olaparib is effective for recurrent urothelial carcinoma with BRCA2 pathogenic germline mutation: first report on olaparib response in recurrent UC

Urothelial carcinoma (UC) is a common malignancy of the lower and upper urinary tract. Recurrent UC has poor prognosis due to delayed diagnosis and a lack of clinical management guidance, especially for upper urinary tract UC. Patients with germline or somatic BRCA1/2 mutations are a special populat...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Ther Adv Med Oncol
Κύριοι συγγραφείς: Yang, Hong, Liu, Zhimin, Wang, Yufang, Li, Jun, Li, Ruiqian, Wang, Qilin, Hu, Chen, Jiang, Haiyang, Wu, Hongyi, Song, Lele, Bai, Yu
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: SAGE Publications 2020
Θέματα:
Case Report
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7675892/
https://ncbi.nlm.nih.gov/pubmed/33240400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920970845
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια